For example, elevated IRF4 expression has been linked to an immunosuppressive TME that favors follicular lymphoma progression [69], whereas diminished IRF4 levels impair immune surveillance and facilitate tumor progression in chronic lymphocytic leukemia [70]. The gene discussed is IRF4; the disease is follicular lymphoma.